We are live on
!
Find out more
VFA
Values First Advisors Portfolio holdings
AUM
$192M
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$12.1M
(+7.1%)
Cap. Flow
+$761K
Cap. Flow
% of AUM
0.41%
Top 10 Holdings %
Top 10 Hldgs %
28.42%
Holding
196
New
14
Increased
88
Reduced
73
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rollins
ROL
|
+$1.72M |
| 2 |
Microchip Technology
MCHP
|
+$977K |
| 3 |
Gentex
GNTX
|
+$639K |
| 4 |
Cognex
CGNX
|
+$570K |
| 5 |
Chewy
CHWY
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$1.15M |
| 2 |
Medifast
MED
|
+$869K |
| 3 |
The Ensign Group
ENSG
|
+$771K |
| 4 |
Grand Canyon Education
LOPE
|
+$693K |
| 5 |
Amphenol
APH
|
+$551K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Healthcare | 15.61% |
| 3 | Industrials | 10.9% |
| 4 | Consumer Discretionary | 7.42% |
| 5 | Real Estate | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Verisk Analytics
VRSK
$26.4B
| $253K | 0.14% |
+813
| New | +$246K |
|
152
Entergy
ETR
$54.1B
| $251K | 0.14% |
3,018
-14
| -0.5% | -$1.16K |
|
153
Digi International
DGII
$2.52B
| $247K | 0.13% |
+7,096
| New | +$217K |
|
|
CYBR
154
DELISTED
CyberArk
CYBR
| $244K | 0.13% |
+601
| New | +$219K |
|
155
Republic Services
RSG
$66.7B
| $239K | 0.13% |
971
-364
| -27% | -$90K |
|
156
Ferguson
FERG
$44.7B
| $237K | 0.13% |
1,087
-388
| -26% | -$71.4K |
|
157
KLA
KLAC
$275B
| $216K | 0.12% |
+2,410
| New | +$181K |
|
158
NETGEAR
NTGR
$669M
| $210K | 0.11% |
+7,228
| New | +$194K |
|
159
Vital Farms
VITL
$558M
| $204K | 0.11% |
+5,293
| New | +$179K |
|
|
SAGE
160
DELISTED
Sage Therapeutics
SAGE
| $203K | 0.11% |
22,296
+412
| +2% | +$3.03K |
|
161
Rockwell Automation
ROK
$51.4B
| $202K | 0.11% |
+609
| New | +$173K |
|
162
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.68B
| $202K | 0.11% |
2,018
-984
| -33% | -$98.4K |
|
163
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
| $178K | 0.1% |
1,611
+809
| +101% | +$89.2K |
|
164
Tandy Leather Factory
TLF
$19.5M
| $167K | 0.09% |
53,891
+602
| +1% | +$1.77K |
|
|
ELCV
165
Eventide High Dividend ETF
ELCV
$254M
| $157K | 0.09% |
6,192
+695
| +13% | +$16.9K |
|
|
GIFI
166
DELISTED
Gulf Island Fabrication
GIFI
| $121K | 0.07% |
18,184
+55
| +0.3% | +$360 |
|
167
Lifetime Brands
LCUT
$199M
| $115K | 0.06% |
22,530
+686
| +3% | +$2.55K |
|
168
Central Garden & Pet Co Class A
CENTA
$2.41B
| $79.5K | 0.04% |
2,540
+9
| +0.4% | +$281 |
|
169
Timothy Plan International ETF
TPIF
$251M
| $66.4K | 0.04% |
+2,057
| New | +$62.5K |
|
|
AGEN
170
Agenus
AGEN
$249M
| $62.1K | 0.03% |
13,581
+246
| +2% | +$852 |
|
171
Pluri
PLUR
$19.2M
| $60K | 0.03% |
12,124
+250
| +2% | +$1.16K |
|
172
Timothy Plan US Small Cap Core ETF
TPSC
$360M
| $52.4K | 0.03% |
1,355
-1,574
| -54% | -$58.1K |
|
173
Talphera
TLPH
$70.1M
| $45.7K | 0.02% |
99,211
+1,887
| +2% | +$939 |
|
174
AT&T
T
$165B
| $17.3K | 0.01% |
599
+2
| +0.3% | +$55 |
|
175
Inspire Small/Mid Cap Impact ETF
ISMD
$335M
| $13.8K | 0.01% |
388
+42
| +12% | +$1.41K |
|
Similar funds
KWM
SCGDR
KC
CVSC
CA
WIA
AGA
LFIA
Values First Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Values First Advisors held 196 positions worth $184M, up 7.1% from $171M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Values First Advisors's Q2 2025 filing shows 14 new, 88 increased, 73 reduced and 15 closed positions. Its largest new stake was Rollins: 30,743 shares worth $1.73M. The largest sale was Alnylam Pharmaceuticals, an estimated $1.15M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
- Values First Advisors's largest Q2 2025 buy was Rollins: 30,743 shares worth $1.73M.
- Values First Advisors added most to Microchip Technology in Q2 2025, an estimated $977K increase.
- Values First Advisors's biggest Q2 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.15M.
- Values First Advisors fully exited Medifast in Q2 2025, selling an estimated $869K.
- Values First Advisors's ten largest holdings make up 28% of its $184M portfolio in Q2 2025.
- Values First Advisors opened 14 new positions and closed 15 in Q2 2025.
- Values First Advisors's portfolio value rose 7.1% quarter-over-quarter to $184M.
Based on Values First Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.